Opsumit

ACC23: J&J's combo pill of Opsumit plus tadalafil improves blood flow in PAH patients
Fierce Pharma
Mon, 03/6/23 - 10:51 am
JNJ
ACC
Opsumit
Opsynvi
Actelion drug fails trial, denting revenue potential
Yahoo/Reuters
Mon, 01/23/17 - 10:19 am
Actelion
clinical trials
Opsumit
PAH
pulmonary arterial hypertension
With Opsumit launch rolling, Actelion doesn't 'need' M&A: CEO
Fierce Pharma
Tue, 10/20/15 - 09:53 pm
Actelion
Opsumit
M&A
PAH
pulmonary arterial hypertension
Actelion's Opsumit growth heralds smooth switch off aging Tracleer
Fierce Pharma
Tue, 07/21/15 - 10:34 am
Actelion
Opsumit
Tracleer
PAH
pulmonary arterial hypertension
Actelion Raises Full-Year Profit Forecast on Opsumit
Bloomberg
Tue, 07/22/14 - 08:58 am
Actelion
Opsumit
Tracleer
earnings
Actelion’s Lung Drug May Face Study Against Gilead Rival
Bloomberg
Wed, 02/12/14 - 09:50 am
Actelion
Gilead Sciences
Opsumit
Letairis
PAH
pulmonary arterial hypertension
Actelion lifts profit view on strong start for new drug
Yahoo/Reuters
Tue, 02/11/14 - 08:50 am
Actelion
earnings
Opsumit
Actelion gets second boost for Opsumit with EU approval
Fierce Pharma
Mon, 12/23/13 - 03:23 pm
Actelion
Opsumit
Europe
Tracleer
PAH
pulmonary arterial hypertension
Actelion’s Drug Approval Seen Enticing Buyers: Real M&A
Bloomberg
Mon, 10/28/13 - 08:32 am
M&A
Actelion
Opsumit
Bayer
Actelion hits 6-yr high after favourable FDA approval for drug
Yahoo/Reuters
Mon, 10/21/13 - 08:36 am
FDA
Actelion
Opsumit
PAH
Actelion Wins U.S. FDA Approval for Lung Disorder Therapy
Bloomberg
Fri, 10/18/13 - 05:47 pm
Actelion
FDA
Opsumit
PAH
Data on Actelion's Opsumit Published
Yahoo/Zacks
Sat, 08/31/13 - 10:31 am
Actelion
Opsumit
pulmonary arterial hypertension